Infliximab - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
INFLECTRA infliximab (rmc) 100mg Powder for Injection vial
AUST R: 217066
Active ingredients:
Infliximab

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Apr 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Product will be replaced by IXIFI infliximab 100 mg powder for injection vial ARTG 422316